Company intelligence / Profile preview

Xstrahl

United Kingdom

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Xstrahl provides commercial radiation therapy systems for clinical use in dermatology and oncology, and preclinical research platforms like SARRP for radiation biology studies. No clinical drug trials; focused on device commercialization and research tools.

Therapeutic areas: OncologyDermatologyOther
Modalities: DeviceRadiopharmaceutical
Industry: Therapeutic Medical Devices

Partnerships

Crown BioscienceJohns Hopkins UniversityGenesisCare UK

Beyond the preview

Go deeper on Xstrahl.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xstrahl.

Explore the full profile